SGLT2 Inhibitor Shows Added Benefits in New Analysis of EMPA-REG OUTCOME Trial
Empagliflozin reduced total cardiovascular burden in T2D patients with heart disease Treatment...
Breaking Endocrinology
Mediterranean Diet Associated with Reduced Type 2 Diabetes Risk
Diet positively affects insulin resistance, lipoprotein metabolism, and inflammation The...
TNF-α Inhibitor Proves Mettle in Type 1 Diabetes
Golimumab benefits insulin levels in newly diagnosed patients in phase II trial Treatment with a...
Global Group Issues Inaugural Diabetes-CKD Guidance
Recommendations aim to help clinicians apply evidence to practice, expert says The international...
